Excited!

[anonymous]

Great news today..I was nervous the leadership team would drop the ball again but arcutis seems like a great company that will hopefully hold them accountable to lead successfully. Excited for NSM as well it will be a good time! See you all in September!

 

[anonymous]

Great news today..I was nervous the leadership team would drop the ball again but arcutis seems like a great company that will hopefully hold them accountable to lead successfully. Excited for NSM as well it will be a good time! See you all in September!

It’s a $1,000 cash price foam…You will be selling to primary care that don’t really care or treat that.

 

[anonymous]

It’s a $1,000 cash price foam…You will be selling to primary care that don’t really care or treat that.

Dumbass. 40% of dupixent's eczema sales come from primary care/peds. They very much do treat.

Open your mind you simpleton and maybe some facts will fall in that thick hole.

It costs about $850 for a 60g tube that last around 90 days. I'll let you do that math tweedle dumb.

The real question since they will book all the sales and it wasn't disclosed is what is Montgomery getting paid via commission?

 

[anonymous]

Dumbass. 40% of dupixent's eczema sales come from primary care/peds. They very much do treat.

Open your mind you simpleton and maybe some facts will fall in that thick hole.

It costs about $850 for a 60g tube that last around 90 days. I'll let you do that math tweedle dumb.

The real question since they will book all the sales and it wasn't disclosed is what is Montgomery getting paid via commission?

Another eczema cream / foam…wow. With a PA and Step Edit on every single managed care plan. Tough sale. I bet JM will say it’s the next blockbuster drug because “it works”.